• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharmaceuticals

Roche Holding AG

+ Add to Watchlist

RHO:GR

213.310 EUR 1.310 0.62%

As of 13:46:36 ET on 07/11/2014.

Snapshot for Roche Holding AG (RHO)

Open: 212.460 Day's Range: 211.200 - 214.296 Volume: 1,089
Previous Close: 212.000 52wk Range: 183.910 - 224.040 1-Yr Rtn: +11.89%

Stock Chart for RHO

No chart data available.
  • RHO:GR 213.310
  • 1D
  • 1M
  • 1Y
212.000
Interactive RHO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RHO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 17.3621
Relative P/E vs. DAX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) 14.9160
Est. PEG Ratio 2.8584
Market Cap (M EUR) 186,148.81
Shares Outstanding (M) 160.00
30 Day Average Volume 2,167
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.00%
Cash Dividend (CHF) 7.8000
Dividend Ex-Date 03/06/2014
5 Year Dividend Growth 14.53%
Next Earnings Announcement 07/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RHO

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for RHO

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Severin SchwanChief Executive OfficerAlan HippeChief Financial & IT Officer
Roland DiggelmannCOO:DiagnosticsGottlieb A KellerGeneral Counsel
More Company Profile & Key Executives for RHO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil